Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer

Hypofractionated IMRT without concurrent chemotherapy provides favorable rates of local control and survival for well-selected patients with NSCLC who cannot tolerate standard definitive therapy.